It should take only about 50 days to clearly understand the ramifications of nursing homes’ new Patient-Driven Payment Model, a top provider leader said. “We’re going to know five or six weeks into...
Residents with osteoarthritis more likely to become socially isolated
By
Alicia Lasek
Oct 16, 2019
Elders with osteoarthritis are at risk for social isolation, highlighting an unmet need for screening and care, researchers say.
Trial drug improves vision in age-related macular degeneration
By
Alicia Lasek
Oct 16, 2019
Patients with “dry” age-related macular degeneration have shown dramatic eyesight improvements in a phase 2 clinical drug trial.
Novel eye drops reduce discomfort of dry eye disease, study finds
By
Alicia Lasek
Oct 15, 2019
Patients with dry eye disease experienced reduced signs and symptoms in response to a new eye drop treatment, an early trial has shown.
Risk assessments, profiles key to effective SNF compliance, experts say
By
Danielle Brown
Oct 14, 2019
Skilled nursing providers must base their compliance programs on an accurate risk profile in order for them to be effective, according to two experts.
COPD triples mortality risk in people with rheumatoid arthritis
By
Alicia Lasek
Oct 13, 2019
Cardiopulmonary disease is a particular hazard for people with rheumatoid arthritis, a population-based study has found.
Clinical Briefs for Friday, October 11
By
Alicia Lasek
Oct 10, 2019
Research sheds new light on how brain forms, recalls memories … FDA approves Dexcom G6 Pro continuous glucose monitor … Acute respiratory viral illness surveillance possible in long-term care: study...
Illuminate HC snares Innovator of the Year Gold Award in Tech competition
By
Liza Berger
Oct 10, 2019
The research and development arm of Illuminate HC this year earned the Gold Award in the Innovator of the Year category in the McKnight’s Excellence in Technology Awards competition for its Illuminate...
Non-traumatic tooth loss linked to heart disease
By
Alicia Lasek
Oct 06, 2019
Caregivers should be aware that adults who have lost teeth in non-traumatic ways may be at increased risk of cardiovascular disease.
‘False and misleading’ marketing of drug to LTC providers to cost pharma company nearly $96M
By
Danielle Brown
Sep 29, 2019
A California-based pharmaceutical company has agreed to pay nearly $96 million to resolve False Claims Act violations for its alleged “false and misleading marketing” of a drug to long-term care providers...